Microbix Biosystems Inc. (MBX : TSX)
Common Stock
$0.30
CAD
+0.02 (5.17%)
Last updated: 2026-06-25
MBX
Microbix Biosystems Inc.
WealthAwesomePerformance
1 Day
+5.17%
1 Week
+1.67%
1 Month
+15.09%
YTD
+27.08%
Key Statistics
Market Cap
$39.88M
52W High
$0.34
52W Low
$0.21
P/E Ratio
-
50 Day MA
$0.26
200 Day MA
$0.25
Beta
0.57
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/25/2026 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | 10,503 |
| 6/24/2026 | $0.29 | $0.29 | $0.29 | $0.29 | $0.29 | 2,000 |
| 6/23/2026 | $0.29 | $0.30 | $0.29 | $0.29 | $0.29 | 37,500 |
| 6/22/2026 | $0.30 | $0.31 | $0.30 | $0.30 | $0.30 | 39,000 |
| 6/19/2026 | $0.29 | $0.30 | $0.29 | $0.30 | $0.30 | 19,001 |
| 6/18/2026 | $0.29 | $0.30 | $0.29 | $0.30 | $0.30 | 17,500 |
| 6/17/2026 | $0.29 | $0.31 | $0.29 | $0.31 | $0.31 | 61,000 |
| 6/16/2026 | $0.28 | $0.29 | $0.28 | $0.29 | $0.29 | 2,501 |
| 6/15/2026 | $0.28 | $0.29 | $0.28 | $0.29 | $0.29 | 54,100 |
| 6/12/2026 | $0.29 | $0.30 | $0.29 | $0.30 | $0.30 | 44,974 |
Analyst Price Targets
Based on analyst covering MBX
Wall Street analysts forecast MBX stock price to rise 31.1% over the next 12 months.
Consensus
No RatingAvg. Target
C$0.40
+31.1% Upside
Current Price
C$0.30
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
61.1%
Annualized
90-Day Vol
55.7%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.36
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.32 | C$0.26 โ C$0.40 |
| 60 trading days | C$0.34 | C$0.26 โ C$0.46 |
| 90 trading days | C$0.36 | C$0.25 โ C$0.53 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Financials
- Revenue (TTM)
- $14.81M
- EBITDA
- $-3.87M
- Profit Margin
- -38.62%
- ROE (TTM)
- -20.36%
- EPS (Diluted)
- -0.04
- Book Value
- 0.18
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About MBX
Articles Featuring MBX.TO
Latest articles and analysis covering MBX.TO
Why Microbix Biosystems Inc. stock is skyrocketing today
Microbix Biosystems Inc. has seen a significant uptick in its stock price today, fueled by positive developments in its business operations and a promising financial outlook.
Why Microbix Biosystems Inc. stock is skyrocketing today
Microbix Biosystems Inc. has seen a notable increase in its stock price today, reflecting positive investor sentiment as the company prepares for its upcoming financial results.
Why Microbix Biosystems Inc. stock is sliding today
Microbix Biosystems Inc. is facing a 3.23% drop in its stock price today, closing at CA$0.30. This decline raises questions about the company's financial health, particularly given its recent revenue growth but ongoing net losses.
Why Microbix Biosystems Inc. stock is sliding today
Microbix Biosystems Inc. has seen a sharp decline in its stock price, reflecting investor concerns over its financial performance and market position. With a market cap of CA$39.9 million and a negative profit margin, the company faces significant challenges ahead.
Why Microbix Biosystems Inc. stock is skyrocketing today
Microbix Biosystems Inc. has seen a remarkable surge in its stock price, climbing 6.90% in just one trading day. This increase reflects growing investor confidence in the company's future prospects, despite the absence of recent major announcements.
Why Microbix Biosystems Inc. stock is sliding today
Microbix Biosystems Inc. shares fell 3.33% in the latest trading session, reflecting investor concerns amid a lack of recent news. With a market cap of CA$41.25 million, the company faces challenges in regaining investor confidence.
Why Microbix Biosystems Inc. stock is skyrocketing today
Microbix Biosystems Inc. shares surged by over 5% in the latest trading session, closing at CA$0.30. This increase suggests a positive shift in market sentiment towards the company.
Why Microbix Biosystems Inc. stock is gaining today
Microbix Biosystems Inc. (MBX.TO) has gained 1.79% in the latest trading session, reflecting potential investor optimism ahead of its Q1 2026 financial results.
Why Microbix Biosystems Inc. stock is rising today
Microbix Biosystems Inc. has seen a notable uptick in its stock price, closing up 3.70% in the last trading session, reflecting investor optimism amidst ongoing developments.
Why Microbix Biosystems Inc. stock is rising today
Microbix Biosystems Inc. (MBX.TO) experienced a 3.70% rise in stock price, closing at CA$0.28. This increase reflects investor optimism amidst the company's ongoing efforts in the biotech sector.
Why Microbix Biosystems Inc. stock is rising today
Microbix Biosystems Inc. experienced a significant rise in stock price, closing at CA$0.28, driven by positive investor sentiment and ongoing innovations in its product line.
